首页> 美国卫生研究院文献>other >The Incidence of Cardiovascular Events Is Comparable Between Normoalbuminuric and Albuminuric Diabetic Patients With Chronic Kidney Disease
【2h】

The Incidence of Cardiovascular Events Is Comparable Between Normoalbuminuric and Albuminuric Diabetic Patients With Chronic Kidney Disease

机译:正常白蛋白尿和蛋白尿糖尿病合并慢性肾脏病患者的心血管事件发生率可比

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diabetic kidney disease leads to microalbuminuria and gradually progresses to overt proteinuria with renal insufficiency. Recent studies have demonstrated that 20% to 40% of patients with diabetic kidney disease are normo- to microalbuminuric, despite reduced renal function. We investigated renal and cardiovascular outcomes in patients with diabetes and renal insufficiency who were normo-, micro-, and macroalbuminuric.Patients with diabetes and stage III or IV chronic kidney disease were recruited and divided into normoalbuminuric, microalbuminuric, and macroalbuminuric groups. New-onset cardiovascular events and renal outcomes, defined by end-stage renal disease or a 50% decline in estimated glomerular filtration rate, were evaluated.Among the 1136 study patients, 255 (22.4%) were normoalbuminuric. During a mean follow-up duration of 44 months, the incidence of cardiovascular disease was similar among groups (P = 0.68). However, renal outcomes were significantly more common in patients with macroalbuminuria than in those who were normoalbuminuric or microalbuminuric (P < 0.001). Multivariate Cox analysis identified macroalbuminuria and estimated glomerular filtration rate as independent predictors of renal outcomes. The amount of albuminuria was not associated with cardiovascular events in this population.Although cardiovascular events were similar in patients with diabetic kidney disease and renal insufficiency, renal outcomes differed significantly according to the amount of albuminuria.
机译:糖尿病性肾脏疾病导致微量白蛋白尿,并逐渐发展为明显的蛋白尿,伴有肾功能不全。最近的研究表明,尽管肾功能下降,但糖尿病肾病患者中有20%至40%是正常白蛋白尿。我们调查了常白蛋白,微白蛋白和大白蛋白尿的糖尿病和肾功能不全患者的肾脏和心血管预后,招募患有糖尿病和III或IV期慢性肾脏病的患者,并将其分为正常白蛋白尿,微白蛋白尿和大白蛋白尿。评估新发的心血管事件和肾结局,定义为终末期肾脏疾病或估计的肾小球滤过率下降50%。在1136名研究患者中,有255名(22.4%)为正常白蛋白尿。在平均44个月的随访期间,各组之间心血管疾病的发生率相似(P = 0.68)。然而,与白蛋白尿或微白蛋白尿患者相比,大蛋白尿患者的肾脏结局明显更为常见(P <0.001)。多元Cox分析确定了巨蛋白尿和估计的肾小球滤过率是肾预后的独立预测因子。该人群的蛋白尿量与心血管事件无关。尽管糖尿病肾病和肾功能不全的患者的心血管事件相似,但肾蛋白结石量却有明显差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号